Movatterモバイル変換


[0]ホーム

URL:


WO1994007434A1 - Breast implant with radiolucent shell - Google Patents

Breast implant with radiolucent shell
Download PDF

Info

Publication number
WO1994007434A1
WO1994007434A1PCT/US1993/007384US9307384WWO9407434A1WO 1994007434 A1WO1994007434 A1WO 1994007434A1US 9307384 WUS9307384 WUS 9307384WWO 9407434 A1WO9407434 A1WO 9407434A1
Authority
WO
WIPO (PCT)
Prior art keywords
shell
radiolucent
breast implant
urethane
polyester urethane
Prior art date
Application number
PCT/US1993/007384
Other languages
French (fr)
Inventor
Terry Russell Knapp
Winston A. Andrews
Original Assignee
Lipomatrix, Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipomatrix, IncorporatedfiledCriticalLipomatrix, Incorporated
Priority to CA002142996ApriorityCriticalpatent/CA2142996C/en
Priority to BR9307139Aprioritypatent/BR9307139A/en
Priority to EP93919900Aprioritypatent/EP0693910A1/en
Priority to AU49983/93Aprioritypatent/AU683223B2/en
Priority to JP6509011Aprioritypatent/JPH09506516A/en
Publication of WO1994007434A1publicationCriticalpatent/WO1994007434A1/en

Links

Classifications

Definitions

Landscapes

Abstract

A breast implant includes a shell fashioned from one of a group of materials which exhibit radiolucency at those x-ray intensities normally encountered for mammographic procedures. The radiolucent shell may be filled with radiolucent fill material as previously taught to thereby comprise a fully radiolucent breast implant. The radiolucent breast implant enhances the use of mammography in detecting tumors in patients having breast implants to more effectively diagnose and treat cancer.

Description

BREAST IMPLANT WITH RADIOLUCENT SHELL Background and Summary of the Invention
Breast pros heses are well known in the art and generally include a shell or envelope which is filled with a fluid or gel which desirably is used to enlarge the female breast yet retain its normal appearance, move¬ ment, feel, and other cosmetic characteristics. Until recently, the predominant breast implant had been a sili- cone envelope filled with a silicone gel. However, re¬ cent health concerns have prompted the withdrawal of this implant from the market. These concerns generally relate to the health risks caused by migration of the silicone gel from within the shell, breakage of the shell, or other introduction of the silicone gel into the body.
The assignee of the present invention also holds certain rights under U.S. Patent No. 4,995,882, the dis¬ closure of which is incorporated herein by reference, which discloses and claims a breast implant comprised of a silicone shell filled with a radiolucent fill material such as peanut oil, sunflower seed oil, or any other suitable fluid with the same atomic number as breast tissue, Z=5.9. As explained in greater detail therein, mammograms typically are performed by compressing a breast between two plates which flattens the breast and enables a more uniform exposure. A controlled intensity of x-rays are then passed through the breast for a care- fully controlled time period to image any artifacts in¬ dicative of cancer. As is well known in the art of mam- mography, great care is taken to minimize the amount of x-ray energy used as studies have shown that certain levels of x-ray exposure will itself increase the risk of developing cancer. Typically, mammographies are conduct¬ ed at low x-ray energy levels, such as between the range of 25-60 kVp. Hence, this prior patent discloses a use¬ ful and valuable invention of utilizing a fill material which is radiolucent using standard mammographic proce- dures and protocols, and perhaps more importantly, x-ray intensities.
The inventors herein are also aware of U.S. Patent No. 4,863,470 which discloses a standard breast implant comprised of a silicone shell with a silicone gel fill material. As previously mentioned herein, this breast implant construction is well known in the prior art and, up until recently, had been the most popular implant used. In addition, this patent discloses an identifica¬ tion marker or tab which is made from silicone with bis- muth trioxide or barium sulfate, both of which are much more "radiopaque" than the silicone used for the standard shell or fill material. Hence, presuming an increased x- ray intensity which would render the standard silicone breast implant radiolucent, a marker or tab would remain opaque and thusly visible. This patent also describes a technique used to read this radiopaque marker which is more similar to a chest x-ray than to a mammogram. As taught therein, the patient lies on her back and the x- rays are directed through her breast and chest cavity. For chest x-rays, energy levels at 125 kVp are common. The intensity of x-rays required for this procedure sub- stantially exceeds that carefully controlled and timed dosage which is used for mammographic procedures. There¬ fore, while this patent suggests that a standard silicone gel and silicone fill material may be radiolucent, it is in reality radiopaque for standard mammographic proce¬ dures. This deficiency with this prior art implant con¬ struction was recognized and dramatically improved upon with the breast implant with radiolucent fill disclosed and claimed in prior U.S. Patent 4,995,882. As an enhancement to the breast implant with silicone shell and radiolucent fill, the inventors herein have succeeded in developing a breast implant with a shell which is also radiolucent. Therefore, with this breast implant, not only is the fill material comprised of a radiolucent material, but the shell also is radiolu¬ cent itself, using the standards for judging radiolucency as explained in prior U.S. Patent 4,995,882, i.e. using standard mammographic protocols, procedures, and intensi¬ ties. The material which the inventors have identified and are contemplating for use for the shell include any one or more of the following: linear aliphatic polyether urethane; linear aliphatic polyester urethane; cyclic aliphatic polyether urethane; cyclic aliphatic polyester urethane; aromatic polyether urethane; aromatic polyester urethane; polybutylene; polypropylene; crosslinked ole- finic elastomers; and styrene-ethylene/butylene-styrene block copolymer. All of these materials have an effec¬ tive atomic number of 6.0 within a range of ±0.5, and therefore exhibit the effective atomic number of fat which is the major component of a human breast. Thus, with the present invention, a breast implant is disclosed which includes a radiolucent shell filled with a radiolu¬ cent fill material thereby rendering the entire implant optimally radiolucent for mammographic procedures. It is not believed that a drawing is required or even helpful in understanding the present invention and, hence, none is being submitted.
Detailed Description of the Preferred Embodiment The inventors' preferred embodiment for achieving a breast implant shell which is essentially radiolucent using standard mammographic procedures, protocols, and intensities. The inventors believe that materials having an effective atomic number of 6.0 within a range of ±0.5 satisfy this criteria. As examples thereof, the present invention includes fashioning the shell from any one of a number of materials such as: linear aliphatic polyether urethane; linear aliphatic polyester urethane; cyclic aliphatic polyether urethane; cyclic aliphatic polyester urethane; aromatic polyether urethane; aromatic polyester urethane; polybutylene; polypropylene; crosslinked ole- finic elastomers; and styrene-ethylene/butylene-styrene block copolymer. It is anticipated that standard manu¬ facturing techniques well known to those of ordinary skill in the art for producing breast implants will be similarly used with the materials of the present inven¬ tion. In other words, it is not anticipated that there will be any difficulty encountered by those of ordinary skill in the art in making breast implant shells with the materials suggested herein as radiolucent.
There are various changes and modifications which may be made to the invention as would be apparent to those skilled in the art. However, these changes or modifications are included in the teaching of the disclo- sure, and it is intended that the invention be limited only by the scope of the claims appended hereto.

Claims

What Is Claimed Is:
1. A breast implant comprised of a shell filled with a filler, both said shell and filler being each made of materials which are themselves substantially radiolu¬ cent under accepted mammographic protocols and intensi¬ ties.
2. The implant of Claim 1 wherein said shell is a material selected from the group consisting of linear aliphatic polyether urethane; linear aliphatic polyester urethane; cyclic aliphatic polyether urethane; cyclic aliphatic polyester urethane; aromatic polyether urethane; aromatic polyester urethane; polybutylene; polypropylene; crosslinked olefinic elastomers; and sty- rene-ethylene/butylene-styrene block copolymer.
3. In a breast implant comprised of a shell filled with a fill material, the improvement comprising said shell being made of a material which is itself substan¬ tially radiolucent under accepted mammographic protocols and intensities.
4. The shell of Claim 3 wherein said shell is a material selected from the group consisting of linear aliphatic polyether urethane; linear aliphatic polyester urethane; cyclic aliphatic polyether urethane; cyclic aliphatic polyester urethane; aromatic polyether ure¬ thane; aromatic polyester urethane; polybutylene; poly¬ propylene; crosslinked olefinic elastomers; and styrene- ethylene/butylene-styrene block copolymer.
5. A breast implant comprised of a shell filled with a filler, both said shell and filler being made of materials having an effective atomic number of 6.0 within a range of about ±0.5.
PCT/US1993/0073841992-09-291993-08-06Breast implant with radiolucent shellWO1994007434A1 (en)

Priority Applications (5)

Application NumberPriority DateFiling DateTitle
CA002142996ACA2142996C (en)1992-09-291993-08-06Breast implant with radiolucent shell
BR9307139ABR9307139A (en)1992-09-291993-08-06 Breast implant and shell filled with a filling material included in a breast implant
EP93919900AEP0693910A1 (en)1992-09-291993-08-06Breast implant with radiolucent shell
AU49983/93AAU683223B2 (en)1992-09-291993-08-06Breast implant with radiolucent shell
JP6509011AJPH09506516A (en)1992-09-291993-08-06 Breast implant with radiolucent encapsulation

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US95268792A1992-09-291992-09-29
US07/952,6871992-09-29

Publications (1)

Publication NumberPublication Date
WO1994007434A1true WO1994007434A1 (en)1994-04-14

Family

ID=25493141

Family Applications (1)

Application NumberTitlePriority DateFiling Date
PCT/US1993/007384WO1994007434A1 (en)1992-09-291993-08-06Breast implant with radiolucent shell

Country Status (6)

CountryLink
EP (1)EP0693910A1 (en)
JP (1)JPH09506516A (en)
AU (1)AU683223B2 (en)
BR (1)BR9307139A (en)
CA (1)CA2142996C (en)
WO (1)WO1994007434A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0727232A3 (en)*1995-02-141996-11-06Mentor CorpFilling material for soft tissue implant prostheses and implants made therewith
WO1998010803A1 (en)*1996-09-131998-03-19Lipomatrix IncorporatedHydraulic foam tissue implant
US5941909A (en)*1995-02-141999-08-24Mentor CorporationFilling material for soft tissue implant prostheses and implants made therewith
US6290723B1 (en)1994-06-142001-09-18Winston A. AndrewsMethod of making a synthetic triglyceride filler material

Citations (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4995882A (en)*1989-08-281991-02-26Washington UniversityRadiolucent breast implant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5141581A (en)*1972-10-081992-08-25Markham Harold AImplants with a cover which resists formation of firm spherical encapsulation
US4157085A (en)*1978-03-241979-06-05Dow Corning CorporationSurgically implantable tissue expanding device and the method of its use
FR2675049A1 (en)*1991-04-091992-10-16Mas Jean ClaudeImplantable mammary prosthesis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4995882A (en)*1989-08-281991-02-26Washington UniversityRadiolucent breast implant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references ofEP0693910A4*

Cited By (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6290723B1 (en)1994-06-142001-09-18Winston A. AndrewsMethod of making a synthetic triglyceride filler material
EP0727232A3 (en)*1995-02-141996-11-06Mentor CorpFilling material for soft tissue implant prostheses and implants made therewith
US5658329A (en)*1995-02-141997-08-19Mentor CorporationFilling material for soft tissue implant prostheses and implants made therewith
US5941909A (en)*1995-02-141999-08-24Mentor CorporationFilling material for soft tissue implant prostheses and implants made therewith
EP1382313A1 (en)*1995-02-142004-01-21Mentor CorporationFilling material for soft tissue implant prostheses and implants made therewith
EP1382356A1 (en)*1995-02-142004-01-21Mentor CorporationFilling material for soft tissue implant prostheses and implants made therewith
WO1998010803A1 (en)*1996-09-131998-03-19Lipomatrix IncorporatedHydraulic foam tissue implant

Also Published As

Publication numberPublication date
CA2142996C (en)2004-03-02
AU4998393A (en)1994-04-26
JPH09506516A (en)1997-06-30
BR9307139A (en)1999-03-30
EP0693910A4 (en)1995-08-03
AU683223B2 (en)1997-11-06
CA2142996A1 (en)1994-04-14
EP0693910A1 (en)1996-01-31

Similar Documents

PublicationPublication DateTitle
DE3872191T2 (en) CHEST PROSTHESIS WITH SEVERAL CHAMBERS.
US4995882A (en)Radiolucent breast implant
EP0521015B1 (en)Bio-osmotic gel for implant prostheses
US8680498B2 (en)Method of utilizing an implant in a human breast
US20060229721A1 (en)Solid implant
Bostwick 3rd et al.Conservative treatment for breast cancer. Complications requiring reconstructive surgery
Schulte et al.Vertebral body replacement with a bioglass-polyurethane composite in spine metastases–clinical, radiological and biomechanical results
Morita et al.Late effects on the eye of conformation radiotherapy for carcinoma of the paranasal sinuses and nasal cavity
Daniels et al.CT recognition of optic nerve sheath meningioma: abnormal sheath visualization.
Sealy et al.Progress in the use of iodine therapy for tumours of the eye
CA2142996C (en)Breast implant with radiolucent shell
Hamilton et al.The use of gold foil wrapping for radiation protection of the spinal cord for recurrent tumor therapy
Murali et al.Chordoma of the cervical spine
CA2142900A1 (en)Penile implant with triglyceride fill
US5653758A (en)Method of using a radiolucent organ displacement device for radiation therapy
Young et al.The relative radiolucencies of breast implant filler materials
Apesos et al.Silicone granuloma following closed capsulotomy of mammary prosthesis
Molteno et al." Physiological" orbital implant
Handel et al.An in vivo study of the effect of various breast implant filler materials on mammography
Hueston et al.Rupture of subpectoral prostheses during closed compression capsulotomy
Kumar et al.Reversal of visual impairment after interstitial irradiation of pituitary tumor
Pradeep Kumar et al.High‐activity iodine‐125 endocurietherapy for head and neck tumors
StraxImaging. Follow‐up of breast cancer reconstruction cases
RU2801711C1 (en)Method of reconstructing the bones of the orbit
Khangure et al.High resolution CT air cisternography in the diagnosis of small acoustic neuromas

Legal Events

DateCodeTitleDescription
AKDesignated states

Kind code of ref document:A1

Designated state(s):AU BB BG BR BY CA CZ FI HU JP KP KR KZ LK MG MN MW NO NZ PL RO RU SD SK UA VN

ALDesignated countries for regional patents

Kind code of ref document:A1

Designated state(s):AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPERequest for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121Ep: the epo has been informed by wipo that ep was designated in this application
WWEWipo information: entry into national phase

Ref document number:2142996

Country of ref document:CA

WWEWipo information: entry into national phase

Ref document number:1993919900

Country of ref document:EP

WWPWipo information: published in national office

Ref document number:1993919900

Country of ref document:EP

WWWWipo information: withdrawn in national office

Ref document number:1993919900

Country of ref document:EP


[8]ページ先頭

©2009-2025 Movatter.jp